Publications by authors named "Peter Bohlen"

Claim this Profile
H
Hierarchical differences in the encoding of sound and choice in the subcortical auditory system.
Chase A Mackey, Margit Dylla, Peter Bohlen, Jason Grigsby, Andrew Hrnicek

J Neurophysiol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Intrinsically Caused Tripping Events in Individuals With Stroke.
Fan Zhang, Peter Bohlen, Michael D Lewek, He Huang

IEEE Trans Neural Syst Rehabil Eng· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial and temporal disparity in signals and maskers affects signal detection in non-human primates.
Francesca Rocchi, Margit E Dylla, Peter A Bohlen, Ramnarayan Ramachandran

Hear Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of environmental factors on level of trip disturbance: a simulation study.
Ming Liu, Peter Bohlen, He Helen Huang

Annu Int Conf IEEE Eng Med Biol Soc· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of modulated tones in modulated noise by non-human primates.
Peter Bohlen, Margit Dylla, Courtney Timms, Ramnarayan Ramachandran

J Assoc Res Otolaryngol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2.
Matthew A J Duncton, Eugene L Piatnitski Chekler, Reeti Katoch-Rouse, Dan Sherman, Wai C Wong, Peter Bohlen

Bioorg Med Chem· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys.
Haijun D Sun, Maria Malabunga, James R Tonra, Roberto DiRenzo, Francine E Carrick, Peter Bohlen

Am J Physiol Endocrinol Metab· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma.
Yan Wu, Andrea T Hooper, Zhaojing Zhong, Larry Witte, Peter Bohlen

Int J Cancer· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling.
Loïc Vincent, Pouneh Kermani, Lauren M Young, Joseph Cheng, Fan Zhang, Peter Bohlen

J Clin Invest· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid vessel regression, protease inhibition, and stromal normalization upon short-term vascular endothelial growth factor receptor 2 inhibition in skin carcinoma heterotransplants.
Daniel W Miller, Silvia Vosseler, Nicolae Mirancea, Daniel J Hicklin, Peter Bohlen

Am J Pathol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
Katrin Lamszus, Marc A Brockmann, Carmen Eckerich, Peter Bohlen, Chad May

Clin Cancer Res· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature.
Chad May, Jacqueline F Doody, Rashed Abdullah, Paul Balderes, Xiaohong Xu, Peter Bohlen

Blood· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fully human recombinant IgG-like bispecific antibody to both the epidermal growth factor receptor and the insulin-like growth factor receptor for enhanced antitumor activity.
Dan Lu, Haifan Zhang, Henry Koo, James Tonra, Paul Balderes, Peter Bohlen

J Biol Chem· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conservation of receptor antagonist anti-tumor activity by epidermal growth factor receptor antibody expressed in transgenic corn seed.
Dale L Ludwig, Larry Witte, Daniel J Hicklin, Marie Prewett, Rajiv Bassi, Peter Bohlen

Hum Antibodies· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fetal stromal-dependent paracrine and intracrine vascular endothelial growth factor-a/vascular endothelial growth factor receptor-1 signaling promotes proliferation and motility of human primary myeloma cells.
Loïc Vincent, David K Jin, Matthias A Karajannis, Koji Shido, Andrea T Hooper, Peter Bohlen

Cancer Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the vascular endothelial cell (VE)-specific adhesion molecule VE-cadherin blocks gonadotropin-dependent folliculogenesis and corpus luteum formation and angiogenesis.
Gary S Nakhuda, Ralf C Zimmermann, Peter Bohlen, Fang Liao, Mark V Sauer

Endocrinology· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The vascular endothelial growth factor (VEGF)/VEGF receptor 2 pathway is critical for blood vessel survival in corpora lutea of pregnancy in the rodent.
Samuel A Pauli, Hongyan Tang, Jeff Wang, Peter Bohlen, Robert Posser

Endocrinology· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic target.
Nick Loizos, Yan Xu, Jim Huber, Meilin Liu, Dan Lu, Peter Bohlen

Mol Cancer Ther· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants.
Silvia Vosseler, Nicolae Mirancea, Peter Bohlen, Margareta M Mueller, Norbert E Fusenig

Cancer Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101.
Fabian Kiessling, Nabeel Farhan, Matthias P Lichy, Silvia Vosseler, Melanie Heilmann, Peter Bohlen

Neoplasia· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2.
Haifan Zhang, Yiwen Li, Hongli Li, Rajiv Bassi, Xenia Jimenez, Peter Bohlen

Leuk Lymphoma· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia.
Rainer Kunstfeld, Satoshi Hirakawa, Young-Kwon Hong, Vivien Schacht, Bernhard Lange-Asschenfeldt, Peter Bohlen

Blood· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of leukemia expressing wild-type or ITD-mutant FLT3 receptor by a fully human anti-FLT3 neutralizing antibody.
Yiwen Li, Hongli Li, Mei-Nai Wang, Dan Lu, Rajiv Bassi, Peter Bohlen

Blood· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins.
Young-Kwon Hong, Bernhard Lange-Asschenfeldt, Paula Velasco, Satoshi Hirakawa, Rainer Kunstfeld, Peter Bohlen

FASEB J· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis.
Scott T Avecilla, Koichi Hattori, Beate Heissig, Rafael Tejada, Fang Liao, Peter Bohlen

Nat Med· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis